Indivior PLC Ordinary Shares (INDV NASDAQ) stock market data APIs
$23.0011
0.19(0.8%)
as of September 15, 2025
Try our APIs with
free plan!
Indivior PLC Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Prev. Close
23.0011
Open
23.1943
High
23.1427
Low
22.509
52 wk Range
7.33-25.1
Market Cap
2 896 M
P/E Ratio
28.6543
Shares Outstanding
125 M
Revenue
1 173 M
EPS
0.51
Beta
1.061
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Indivior PLC Ordinary Shares (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Indivior PLC Ordinary Shares data using free add-ons & libraries
Get Indivior PLC Ordinary Shares Fundamental Data
Indivior PLC Ordinary Shares Fundamental data includes:
- Net Revenue: 1 173 M
- EBITDA: 336 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-31
- EPS/Forecast: 0.24
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Indivior PLC Ordinary Shares News
New
Top 100 Stocks to Buy: Indivior Advances Into Top 50 on Momentum
Indivior (INDV) moved up 11 positions on Monday into the 46th spot on Barchart’s Top 100 Stocks to Buy. The opioid-treatment pharmaceutical company was one of only eight stocks in the top 50 to gain...
Indivior explores alternatives for Opvee, announces restructuring details
[Business agreement] mediaphotos/iStock via Getty Images Indivior (NASDAQ:INDV [https://seekingalpha.com/symbol/INDV]) announced on Tuesday that it is exploring strategic options for its nasal opioid...
Form 8K Indivior PLC For: 22 August
Catalyst Watch: Spotlight on Nvidia, Alibaba, PCE inflation read, and the return of Bed Bath & Beyond
[Money flow positive in asia investment economic stockmarket growth in developed country showing stock chart down and in business and financial money market crisis concept] primeimages Welcome to See...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
